Bank of New York Mellon »

Maplight Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-12-31 $630k 36k 17.57

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl C Cap (GOOG)
Ishares Core S&p 500 Etf Core (IVV)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Maplight Therapeutics

T. Rowe Price Investment Management
Goldman Sachs Group
Vanguard Group
Geode Capital Management
State Street Corporation
Lazard Asset Management
Freestone Grove Partners
Bnp Paribas Investment Partners
Charles Schwab Investment Management
Marshall Wace
TD Asset Management
Bank of New York Mellon
Barclays
Wells Fargo & Company
UBS Group

View all funds holding Maplight Therapeutics